Mikasa K - Search Results

1

Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.

Kita E, Yunou Y, Kurioka T, Harada H, Yoshikawa S, Mikasa K, Higashi N. Kita E, et al. Among authors: mikasa k. Infect Immun. 2000 Mar;68(3):1207-14. doi: 10.1128/IAI.68.3.1207-1214.2000. Infect Immun. 2000. PMID: 10678928 Free PMC article.

2

[The 5th report on long-term chemotherapy using erythromycin (EM) for chronic lower airway infection--cases followed over 7 years].

Mikasa K, Sawaki M, Kita E, Konishi M, Maeda K, Takeuchi S, Hamada K, Kunimatsu M, Imai T, Sasaki Y, et al. Mikasa K, et al. Kansenshogaku Zasshi. 1992 Oct;66(10):1390-5. doi: 10.11150/kansenshogakuzasshi1970.66.1390. Kansenshogaku Zasshi. 1992. PMID: 1293219 Japanese.

3

[The long-term chemotherapy with erythromycin (EM) in chronic lower respiratory tract infections--third report: clinical study of cases administered EM over 3 years].

Mikasa K, Sawaki M, Konishi M, Maeda K, Takeuchi S, Hamada K, Kunimatsu M, Masutani T, Sano R, Kita E, et al. Mikasa K, et al. Kansenshogaku Zasshi. 1992 May;66(5):561-7. doi: 10.11150/kansenshogakuzasshi1970.66.561. Kansenshogaku Zasshi. 1992. PMID: 1402088 Japanese.

4

[Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases--the fourth report].

Mikasa K, Sawaki M, Kita E, Konishi M, Maeda K, Hamada K, Takeuchi S, Masutani T, Sano R, Kunimatsu M, et al. Mikasa K, et al. Kansenshogaku Zasshi. 1992 Aug;66(8):1097-104. doi: 10.11150/kansenshogakuzasshi1970.66.1097. Kansenshogaku Zasshi. 1992. PMID: 1402116 Japanese.

5

The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice.

Mikasa K, Kita E, Sawaki M, Kunimatsu M, Hamada K, Konishi M, Kashiba S, Narita N. Mikasa K, et al. J Antimicrob Chemother. 1992 Sep;30(3):339-48. doi: 10.1093/jac/30.3.339. J Antimicrob Chemother. 1992. PMID: 1452499

6

Suppression of virulence factors of Pseudomonas aeruginosa by erythromycin.

Kita E, Sawaki M, Oku D, Hamuro A, Mikasa K, Konishi M, Emoto M, Takeuchi S, Narita N, Kashiba S. Kita E, et al. Among authors: mikasa k. J Antimicrob Chemother. 1991 Mar;27(3):273-84. doi: 10.1093/jac/27.3.273. J Antimicrob Chemother. 1991. PMID: 1903786

7

Enhanced interleukin production after long-term administration of erythromycin stearate.

Kita E, Sawaki M, Nishikawa F, Mikasa K, Yagyu Y, Takeuchi S, Yasui K, Narita N, Kashiba S. Kita E, et al. Among authors: mikasa k. Pharmacology. 1990;41(4):177-83. doi: 10.1159/000138716. Pharmacology. 1990. PMID: 2080228

8

Murine tumorlytic factor, immunologically distinct from tumor necrosis factor-alpha and -beta, induced in the serum of mice treated with a T-cell mitogen of Corynebacterium kutscheri.

Kita E, Matsui N, Sawaki M, Mikasa K, Katsui N. Kita E, et al. Among authors: mikasa k. Immunol Lett. 1995 May;46(1-2):101-6. doi: 10.1016/0165-2478(95)00029-5. Immunol Lett. 1995. PMID: 7590903

9

Restoration of the acute phase response after infection in cyclophosphamide-treated mice by granulocyte colony-stimulating factor.

Sawaki M, Kita E, Mikasa K, Konishi M, Kumimatsu M, Kashiba S, Narita N. Sawaki M, et al. Among authors: mikasa k. Biotherapy. 1993;6(1):51-61. doi: 10.1007/BF01877386. Biotherapy. 1993. PMID: 7685182

10

Antitumor effect of erythromycin in mice.

Hamada K, Kita E, Sawaki M, Mikasa K, Narita N. Hamada K, et al. Among authors: mikasa k. Chemotherapy. 1995 Jan-Feb;41(1):59-69. doi: 10.1159/000239325. Chemotherapy. 1995. PMID: 7875024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters